Morton J J, Beattie E C, Speirs A, Gulliver F
MRC Blood Pressure Unit, Western Infirmary, Glasgow, UK.
J Hypertens. 1993 Oct;11(10):1083-8. doi: 10.1097/00004872-199310000-00012.
To determine whether induction of arterial hypertension in young normotensive Wistar rats by chronic inhibition of nitric oxide production with NG-nitro-L-arginine methyl ester (L-NAME) produced a form of self-sustained hypertension, and to investigate the role of the renin-angiotensin system and vascular hypertrophy in the hypertensive process.
Three-week-old Wistar rats were given 100 or 40 mg/kg per day L-NAME or 40 mg/kg per day L-NAME plus 100 mg/kg per day captopril in their drinking water for between 4 and 7 weeks. Systolic blood pressure was measured by tail-cuff plethysmography both during treatment and after the treatment had been stopped. The effect of treatment on plasma renin was measured and the effect of treatment on mesenteric resistance artery structure was determined using a small-vessel myograph.
L-NAME produced a progressive and marked increase in blood pressure during the period of treatment. Hypertension was sustained for 14 weeks after stopping treatment. L-NAME resulted in a fourfold increase in plasma renin which remained elevated after treatment was stopped. Blood pressure was correlated with plasma renin levels. Treatment with L-NAME plus captopril markedly attenuated the rise in blood pressure and captopril also produced a marked fall in blood pressure in rats that developed persistent hypertension. Rats with self-sustained hypertension exhibited both cardiac and mesenteric resistance vessel hypertrophy. The induction of vascular hypertrophy with low-dose L-NAME did not result in the development of self-sustained hypertension.
Chronic L-NAME treatment in young rats can produce a form of persistent hypertension which is renin-dependent and which does not seem to involve a vascular amplifier mechanism.
确定用N-硝基-L-精氨酸甲酯(L-NAME)慢性抑制一氧化氮生成是否会在年轻的血压正常的Wistar大鼠中诱发一种持续性高血压形式,并研究肾素-血管紧张素系统和血管肥厚在高血压过程中的作用。
给3周龄的Wistar大鼠在饮水中每日给予100或40mg/kg的L-NAME,或每日40mg/kg的L-NAME加每日100mg/kg的卡托普利,持续4至7周。在治疗期间和停止治疗后,通过尾套体积描记法测量收缩压。测量治疗对血浆肾素的影响,并使用小型血管肌动描记器确定治疗对肠系膜阻力动脉结构的影响。
在治疗期间,L-NAME使血压进行性显著升高。停止治疗后高血压持续14周。L-NAME使血浆肾素增加四倍,在停止治疗后仍保持升高。血压与血浆肾素水平相关。L-NAME加卡托普利治疗显著减弱了血压升高,卡托普利也使发生持续性高血压的大鼠血压显著下降。患有持续性高血压的大鼠表现出心脏和肠系膜阻力血管肥厚。低剂量L-NAME诱导血管肥厚并未导致持续性高血压的发生。
在年轻大鼠中慢性L-NAME治疗可产生一种持续性高血压形式,这种高血压依赖肾素,且似乎不涉及血管放大机制。